{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T01:22:26Z","timestamp":1782782546529,"version":"3.54.5"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T00:00:00Z","timestamp":1749081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T00:00:00Z","timestamp":1749081600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The National Key R&D Program of China","award":["2022YFF0705200"],"award-info":[{"award-number":["2022YFF0705200"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82072295"],"award-info":[{"award-number":["82072295"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the National Science and Technology Major Project of China","award":["2018ZX09711003"],"award-info":[{"award-number":["2018ZX09711003"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"DOI":"10.1186\/s12985-025-02818-3","type":"journal-article","created":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T17:37:51Z","timestamp":1749145071000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Analysis of the clinical efficacy of CCBs in patients with severe fever with thrombocytopenia syndrome combined with hypertension"],"prefix":"10.1186","volume":"22","author":[{"given":"Ziruo","family":"Ge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenxi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanli","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihai","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,5]]},"reference":[{"key":"2818_CR1","unstructured":"Current ICTV. Taxonomy Release| ICTV[EB\/OL]. https:\/\/ictv.global\/taxonomy"},{"issue":"6","key":"2818_CR2","first-page":"852","volume":"43","author":"Q-L Chen","year":"2022","unstructured":"Chen Q-L, Zhu M-T, Chen N, et al. Epidemiological characteristics of severe fever with thtrombocytopenia syndrome in china, 2011\u20132021[J]. Chin J Epidemiol. 2022;43(6):852\u20139.","journal-title":"Chin J Epidemiol"},{"issue":"9","key":"2818_CR3","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1056\/NEJMoa1203378","volume":"367","author":"LK McMullan","year":"2012","unstructured":"McMullan LK, Folk SM, Kelly AJ, et al. A new phlebovirus associated with severe febrile illness in Missouri[J]. N Engl J Med. 2012;367(9):834\u201341.","journal-title":"N Engl J Med"},{"issue":"8","key":"2818_CR4","first-page":"506","volume":"37","author":"S-P Cui","year":"2019","unstructured":"Cui S-P, Ge Z-R, Chen Z-H. Advances in research on heartland virus disease [J]. Chin J Infect Dis. 2019;37(8):506\u20139.","journal-title":"Chin J Infect Dis"},{"issue":"6","key":"2818_CR5","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.3201\/eid2006.140003","volume":"20","author":"J Wang","year":"2014","unstructured":"Wang J, Selleck P, Yu M, et al. Novel phlebovirus with zoonotic potential isolated from ticks, Australia[J]. Emerg Infect Dis. 2014;20(6):1040\u20133.","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"2818_CR6","doi-asserted-by":"publisher","first-page":"e0009037","DOI":"10.1371\/journal.pntd.0009037","volume":"15","author":"X Fang","year":"2021","unstructured":"Fang X, Hu J, Peng Z, et al. Epidemiological and clinical characteristics of severe fever with thrombocytopenia syndrome bunyavirus human-to-human transmission[J]. PLoS Negl Trop Dis. 2021;15(4):e0009037.","journal-title":"PLoS Negl Trop Dis"},{"key":"2818_CR7","doi-asserted-by":"crossref","unstructured":"Yamanaka A, Kirino Y, Fujimoto S, \u7b49. Direct transmission of severe fever with thrombocytopenia syndrome virus from domestic Cat to veterinary Personnel[J]. Emerg Infect Dis. 2020;26(12):2994\u20138.","DOI":"10.3201\/eid2612.191513"},{"key":"2818_CR8","doi-asserted-by":"crossref","unstructured":"Niu G, Li J, Liang M, \u7b49. Severe fever with thrombocytopenia syndrome virus among domesticated animals, China[J]. Emerg Infect Dis. 2013;19(5):756\u201363.","DOI":"10.3201\/eid1905.120245"},{"issue":"10","key":"2818_CR9","doi-asserted-by":"publisher","first-page":"e0165207","DOI":"10.1371\/journal.pone.0165207","volume":"11","author":"H Kato","year":"2016","unstructured":"Kato H, Yamagishi T, Shimada T, et al. Epidemiological and clinical features of severe fever with thrombocytopenia syndrome in japan, 2013\u20132014[J]. PLoS ONE. 2016;11(10):e0165207.","journal-title":"PLoS ONE"},{"issue":"12","key":"2818_CR10","doi-asserted-by":"publisher","first-page":"e0005264","DOI":"10.1371\/journal.pntd.0005264","volume":"10","author":"SJ Choi","year":"2016","unstructured":"Choi SJ, Park S-W, Bae I-G, et al. Severe fever with thrombocytopenia syndrome in South korea, 2013\u20132015[J]. PLoS Negl Trop Dis. 2016;10(12):e0005264.","journal-title":"PLoS Negl Trop Dis"},{"key":"2818_CR11","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.tmaid.2018.04.010","volume":"23","author":"AJ Rodr\u00edguez-Morales","year":"2018","unstructured":"Rodr\u00edguez-Morales AJ, Ram\u00edrez-Jaramillo V, Pati\u00f1o-Barbosa AM, et al. Severe fever with thrombocytopenia syndrome\u2013 A bibliometric analysis of an emerging priority disease[J]. Travel Med Infect Dis. 2018;23:97\u20138.","journal-title":"Travel Med Infect Dis"},{"key":"2818_CR12","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.coviro.2018.03.005","volume":"29","author":"LM Reece","year":"2018","unstructured":"Reece LM, Beasley DW, Milligan GN, et al. Current status of severe fever with thrombocytopenia syndrome vaccine development[J]. Curr Opin Virol. 2018;29:72\u20138.","journal-title":"Curr Opin Virol"},{"issue":"10","key":"2818_CR13","doi-asserted-by":"publisher","first-page":"e0206416","DOI":"10.1371\/journal.pone.0206416","volume":"13","author":"H Tani","year":"2018","unstructured":"Tani H, Komeno T, Fukuma A, et al. Therapeutic effects of favipiravir against severe fever with thrombocytopenia syndrome virus infection in a lethal mouse model: Dose-efficacy studies upon oral administration[J]. PLoS ONE. 2018;13(10):e0206416.","journal-title":"PLoS ONE"},{"issue":"1","key":"2818_CR14","doi-asserted-by":"publisher","first-page":"e00061","DOI":"10.1128\/mSphere.00061-15","volume":"1","author":"H Tani","year":"2016","unstructured":"Tani H, Fukuma A, Fukushi S, et al. Efficacy of T-705 (Favipiravir) in the treatment of infections with lethal severe fever with thrombocytopenia syndrome Virus[J]. mSphere. 2016;1(1):e00061\u201315.","journal-title":"mSphere"},{"issue":"6","key":"2818_CR15","doi-asserted-by":"publisher","first-page":"423","DOI":"10.7883\/yoken.67.423","volume":"67","author":"M Shimojima","year":"2014","unstructured":"Shimojima M, Fukushi S, Tani H, et al. Effects of ribavirin on severe fever with thrombocytopenia syndrome virus in Vitro[J]. Jpn J Infect Dis. 2014;67(6):423\u20137.","journal-title":"Jpn J Infect Dis"},{"issue":"2","key":"2818_CR16","doi-asserted-by":"publisher","first-page":"e0009103","DOI":"10.1371\/journal.pntd.0009103","volume":"15","author":"K Suemori","year":"2021","unstructured":"Suemori K, Saijo M, Yamanaka A, et al. A multicenter non-randomized, uncontrolled single arm trial for evaluation of the efficacy and the safety of the treatment with favipiravir for patients with severe fever with thrombocytopenia syndrome[J]. PLoS Negl Trop Dis. 2021;15(2):e0009103.","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"2818_CR17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-020-00451-w","volume":"6","author":"H Li","year":"2021","unstructured":"Li H, Jiang X-M, Cui N, et al. Clinical effect and antiviral mechanism of T-705 in treating severe fever with thrombocytopenia syndrome[J]. Signal Transduct Target Therapy. 2021;6(1):1\u201313.","journal-title":"Signal Transduct Target Therapy"},{"issue":"9","key":"2818_CR18","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/s41422-019-0214-z","volume":"29","author":"H Li","year":"2019","unstructured":"Li H, Zhang L-K, Li S-F, et al. CCBs reduce severe fever with thrombocytopenia syndrome virus (SFTSV) related fatality[J]. Cell Res. 2019;29(9):739\u201353.","journal-title":"Cell Res"},{"issue":"3","key":"2818_CR19","doi-asserted-by":"publisher","first-page":"e00015","DOI":"10.1128\/jvi.00015-23","volume":"97","author":"S Urata","year":"2023","unstructured":"Urata S, Yoshikawa R, Yasuda J. Calcium influx regulates the replication of several Negative-Strand RNA viruses including severe fever with thrombocytopenia syndrome Virus[J]. J Virol. 2023;97(3):e00015\u201323.","journal-title":"J Virol"},{"issue":"12","key":"2818_CR20","first-page":"711","volume":"40","author":"Chinese Society of Infectious Diseases, Chinese Medical Association","year":"2022","unstructured":"Chinese Society of Infectious Diseases, Chinese Medical Association. Consensus on the diagnosis and treatment of severe fever with thrombocytopenia syndrome [J]. Chin J Infect Dis. 2022;40(12):711\u201321.","journal-title":"Chin J Infect Dis"},{"key":"2818_CR21","doi-asserted-by":"publisher","first-page":"531","DOI":"10.3389\/fimmu.2019.00531","volume":"10","author":"A Pizzorno","year":"2019","unstructured":"Pizzorno A, Padey B, Terrier O, et al. Drug repurposing approaches for the treatment of influenza viral infection: reviving old drugs to fight against a Long-Lived Enemy[J]. Front Immunol. 2019;10:531.","journal-title":"Front Immunol"},{"issue":"10","key":"2818_CR22","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.tim.2018.04.004","volume":"26","author":"B Mercorelli","year":"2018","unstructured":"Mercorelli B, Pal\u00f9 G, Loregian A. Drug repurposing for viral infectious diseases: how Far are We?[J]. Trends Microbiol. 2018;26(10):865\u201376.","journal-title":"Trends Microbiol"},{"issue":"21","key":"2818_CR23","doi-asserted-by":"publisher","first-page":"e01055","DOI":"10.1128\/JVI.01055-17","volume":"91","author":"S Wang","year":"2017","unstructured":"Wang S, Liu Y, Guo J, et al. Screening of FDA-Approved drugs for inhibitors of Japanese encephalitis virus Infection[J]. J Virol. 2017;91(21):e01055\u201317.","journal-title":"J Virol"},{"issue":"16","key":"2818_CR24","doi-asserted-by":"publisher","first-page":"e00954","DOI":"10.1128\/JVI.00954-18","volume":"92","author":"P Wang","year":"2018","unstructured":"Wang P, Liu Y, Zhang G, et al. Screening and identification of Lassa virus entry inhibitors from an FDA-Approved drug Library[J]. J Virol. 2018;92(16):e00954\u201318.","journal-title":"J Virol"},{"key":"2818_CR25","doi-asserted-by":"publisher","first-page":"105313","DOI":"10.1016\/j.antiviral.2022.105313","volume":"202","author":"B Bezemer","year":"2022","unstructured":"Bezemer B, van Cleef KWR, Overheul GJ, et al. The calcium channel inhibitor lacidipine inhibits Zika virus replication in neural progenitor cells[J]. Antiviral Res. 2022;202:105313.","journal-title":"Antiviral Res"},{"key":"2818_CR26","doi-asserted-by":"crossref","unstructured":"Straus MR, Bidon MK, Tang T et al. Inhibitors of L-Type Calcium Channels Show Therapeutic Potential for Treating SARS-CoV-2 Infections by Preventing Virus Entry and Spread[J]. ACS Infectious Diseases, 2021: acsinfecdis.1c00023.","DOI":"10.1101\/2020.07.21.214577"},{"issue":"1","key":"2818_CR27","first-page":"24","volume":"24","author":"CH League","year":"2019","unstructured":"Writing Group of 2018 Chinese Guidelines for the Management of Hypertension, League CH. Chinese society of cardiology, Chinese medical Doctor association hypertension committee, hypertension branch of China international exchange and promotive association for medical and health care, hypertension branch of Chinese geriatric medical association. 2018 Chinese guidelines for the management of hypertension [J]. Chin J Cardiovasc Med. 2019;24(1):24\u201356.","journal-title":"Chin J Cardiovasc Med"},{"key":"2818_CR28","unstructured":"Hu S-S, Gao R-L, Liu L-S et al. Summary of the 2018 report on cardiovascular diseases in China [J]. Chin Circulation. J, 2019;34(3)."}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-025-02818-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12985-025-02818-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-025-02818-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T17:37:53Z","timestamp":1749145073000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-025-02818-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,5]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2818"],"URL":"https:\/\/doi.org\/10.1186\/s12985-025-02818-3","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,5]]},"assertion":[{"value":"25 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Beijing Ditan Hospital, Capital Medical University (NO. DTEC-KY2022-022-03), and They were conducted using the principles of the Helsinki Declaration. All participants provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"184"}}